Ritalin improves chronic fatigue symptoms in patients with hepatitis C-induced cirrhosis.

被引:0
|
作者
Wolf, DC [1 ]
Loutsch, E [1 ]
Hui, K [1 ]
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
关键词
D O I
10.1016/S0016-5085(00)81900-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
6779
引用
收藏
页码:A1499 / +
页数:2
相关论文
共 50 条
  • [1] To assess the quality of life and symptoms in chronic hepatitis C virus (HCV) infection in the absence of cirrhosis.
    Ahmad, I
    Owens, D
    Ahmed, W
    Khan, H
    Walker, M
    Anderson, G
    GUT, 1999, 44 : A54 - A54
  • [2] Hispanics with chronic hepatitis C have more fibrosis and cirrhosis.
    Carto, VL
    Torres, EA
    Magno, P
    Vazquez, M
    Gonzalez-Keelan, C
    HEPATOLOGY, 2002, 36 (04) : 713A - 713A
  • [3] Viusid, a nutritional supplement, in patients with chronic hepatitis C and cirrhosis. A randomized and controlled study
    Gomez, E. Vilar
    Rodriguez, Y. Sanchez
    Soler, E. Arus
    Oramas, B. Gra
    JOURNAL OF HEPATOLOGY, 2008, 48 : S124 - S124
  • [4] Influence of steatosis on chronic hepatitis C outcome:: Prospective study of 164 patients with cirrhosis.
    Ganne-Carrié, N
    Chevret, S
    Guettier, C
    Ziol, M
    Christidis, C
    Trinchet, JC
    Beaugrand, M
    HEPATOLOGY, 2001, 34 (04) : 218A - 218A
  • [5] Therapeutic effect of ursodeoxycholic acid on chronic hepatitis C with cholestatic cirrhosis.
    Abul-Futuh, AR
    El Hadad, SM
    Solayman, AGM
    Hamed, WA
    HEPATOLOGY, 2001, 34 (04) : 626A - 626A
  • [6] Impaired glucose homeostasis in hepatitis C patients without cirrhosis.
    Pandya, PK
    Alba, L
    Clarkston, WK
    Taylor, R
    Smith, OJ
    Mather, K
    HEPATOLOGY, 2001, 34 (04) : 221A - 221A
  • [7] Increased prevalence of hila class 1 allelic diversity in chronic hepatitis C patients with cirrhosis.
    Patel, K
    Norris, S
    Clare, M
    Pianko, S
    Heaton, S
    Feng, A
    Blatt, LM
    Koziol, C
    Conrad, A
    HEPATOLOGY, 2002, 36 (04) : 278A - 278A
  • [9] IFN prevents the progression of liver cirrhosis and prolongs survival in compensated chronic hepatitis C and cirrhosis.
    Nishiguchi, S
    Nakatani, S
    Minamitani, S
    Fukuda, K
    Tamori, A
    Takeda, T
    Shiomi, S
    Seki, S
    Kuroki, T
    HEPATOLOGY, 1998, 28 (04) : 698A - 698A
  • [10] Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
    Amany Nabil Abbasy
    Hoda Mohamed Abdel-Naby
    Walid Ismail Ellakany
    Egyptian Liver Journal, 13